The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Epidemiology, Risk Factors and Treatments for Antibiotic-Associated Diarrhea
Abstract
Antibiotic-associated diarrhea (AAD) is a common complication of antibiotics and recent findings on the epidemiology, etiologies and treatment strategies are reviewed. Rates of AAD vary from 5 to 39% depending upon the specific type of antibiotic. The severity of AAD may include uncomplicated diarrhea, colitis or pseudomembranous colitis. The pathogenesis of AAD may be mediated through the disruption of the normal flora and overgrowth of pathogens or through metabolic imbalances. The impact of AAD is reflected by increased hospital stays, higher medical costs and increased rates of comorbidity. The key to decreasing these consequences is prompt diagnosis followed by effective treatment and institution of control measures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nosocomial Acquisition of Clostridium difficile Infection
McFarland, L. V., Mulligan, M. E., Kwok, R. Y. Y., & Stamm, W. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901263200402 · Cited by 1,326
Self-citationMcFarland, L. V. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510480037031 · Cited by 857
Self-citationTeasley, D., Olson, M., Gebhard, R., Gerding, D., Peterson, L., Schwartz, M., & Lee, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91036-x · Cited by 785
Absorption of Short-Chain Fatty Acids by the Colon
Ruppin, H., Bar-Meir, S., Soergel, K. H., Wood, C. M., & Schmitt, M. G. (1980) · Gastroenterology · doi:10.1016/s0016-5085(19)30508-6 · Cited by 736
Gonzales, R. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550110039033 · Cited by 717
Clindamycin-Associated Colitis: A Prospective Study
TEDESCO, F. J., BARTON, R. W., & ALPERS, D. H. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-4-429 · Cited by 606
Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study
Surawicz, C. M., Elmer, G. W., Speelman, P., McFarland, L. V., Chinn, J., & Van Belle, G. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)91613-2 · Cited by 573
Self-citationRole of Clostridium difficile in antibiotic-associated pseudomembranous colitis
Bartlett, J. G., Moon, N., Chang, T. W., Taylor, N., & Onderdonk, A. B. (1978) · Gastroenterology · doi:10.1016/0016-5085(78)90457-2 · Cited by 517
Wenisch, C., Parschalk, B., Hasenhundl, M., Hirschl, A. M., & Graninger, W. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.5.813 · Cited by 505
Clindamycin-Associated Colitis Due to a Toxin-Producing Species of Clostridium in Hamsters
Bartlett, J. G., Onderdonk, A. B., Cisneros, R. L., & Kasper, D. L. (1977) · Journal of Infectious Diseases · doi:10.1093/infdis/136.5.701 · Cited by 472
Cited by
Suez, J., Zmora, N., Zilberman-Schapira, G., Mor, U., Dori-Bachash, M., Bashiardes, S., Zur, M., Regev-Lehavi, D., Ben-Zeev Brik, R., Federici, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.047 · Cited by 1,184
Pepin, J. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041104 · Cited by 1,128
Long-term impacts of antibiotic exposure on the human intestinal microbiota
Jernberg, C., Löfmark, S., Edlund, C., & Jansson, J. K. (2010) · Microbiology · doi:10.1099/mic.0.040618-0 · Cited by 1,067
Pepin, J., Saheb, N., Coulombe, M.-A., Alary, M.-E., Corriveau, M.-P., Authier, S., Leblanc, M., Rivard, G., Bettez, M., Primeau, V., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496986 · Cited by 995
McFarland, L. V. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00465.x · Cited by 872
“Risk factors for AAD include broad-spectrum antibiotics, host factors (age, health status, gender), hospitalization status, and exposure to nosocomial pathogens (2, 4).”
BackgroundSelf-citationNewberry, S. J. (2012) · JAMA · doi:10.1001/jama.2012.3507 · Cited by 870
Intestinal microbiota in human health and disease: the impact of probiotics
Gerritsen, J., Smidt, H., Rijkers, G. T., & de Vos, W. M. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0229-7 · Cited by 724
Homeostasis of the gut barrier and potential biomarkers
Wells, J. M., Brummer, R. J., Derrien, M., MacDonald, T. T., Troost, F., Cani, P. D., Theodorou, V., Dekker, J., Méheust, A., de Vos, W. M., et al. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00048.2015 · Cited by 620
Collins, S. M., & Bercik, P. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.075 · Cited by 612
Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Goldenberg, J. Z., Lytvyn, L., Steurich, J., Parkin, P., Mahant, S., & Johnston, B. C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub4 · Cited by 607
Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, Canada
Pepin, J., Alary, M.-E., Valiquette, L., Raiche, E., Ruel, J., Fulop, K., Godin, D., & Bourassa, C. (2005) · Clinical Infectious Diseases · doi:10.1086/430315 · Cited by 570
A Meta-Analysis of Probiotic Efficacy for Gastrointestinal Diseases
Ritchie, M. L., & Romanuk, T. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034938 · Cited by 474
Clostridium difficile spore biology: sporulation, germination, and spore structural proteins
Paredes-Sabja, D., Shen, A., & Sorg, J. A. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.04.003 · Cited by 419
Allen, S. J., Wareham, K., Wang, D., Bradley, C., Hutchings, H., Harris, W., Dhar, A., Brown, H., Foden, A., Gravenor, M. B., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61218-0 · Cited by 383
Johnston, B. C., Ma, S. S. Y., Goldenberg, J. Z., Thorlund, K., Vandvik, P. O., Loeb, M., & Guyatt, G. H. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-12-201212180-00563 · Cited by 367
Antibiotic-Associated Diarrhea: Epidemiology, Trends and Treatment
McFarland, L. V. (2008) · Future Microbiology · doi:10.2217/17460913.3.5.563 · Cited by 333
Self-citationThe Human Microbiome and Its Potential Importance to Pediatrics
Johnson, C. L., & Versalovic, J. (2012) · Pediatrics · doi:10.1542/peds.2011-2736 · Cited by 310
Kotowska, M., Albrecht, P., & Szajewska, H. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02356.x · Cited by 286
Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Guo, Q., Goldenberg, J. Z., Humphrey, C., El Dib, R., & Johnston, B. C. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub5 · Cited by 275
“Clostridium difficile (C. difficile) overgrowth is the bacterial agent most associated with AAD (McFarland 2008; McFarland 1998; Bartlett 1978).”
BackgroundInfluentialProbiotics for the Prevention of Antibiotic‐Associated Diarrhea in Children
Szajewska, H., Canani, R. B., Guarino, A., Hojsak, I., Indrio, F., Kolacek, S., Orel, R., Shamir, R., Vandenplas, Y., van Goudoever, J. B., et al. (2016) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001081 · Cited by 268
Probiotic approach to prevent antibiotic resistance
Ouwehand, A. C., Forssten, S., Hibberd, A. A., Lyra, A., & Stahl, B. (2016) · Annals of Medicine · doi:10.3109/07853890.2016.1161232 · Cited by 216
“AAD is relatively common with a prevalence varying 5–35% depending on the type of antibiotic and length of treatment, age, concomitant diseases and hospitalization (20,21).”
BackgroundBlaabjerg, S., Artzi, D., & Aabenhus, R. (2017) · Antibiotics · doi:10.3390/antibiotics6040021 · Cited by 208
“Antibiotic-associated diarrhea (AAD) occurs in 5% to 39% of patients, from the beginning and up to two months after the end of treatment [1].”
BackgroundTreatment and prevention of antibiotic associated diarrhea
Bergogne-Bérézin, E. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00293-4 · Cited by 174
Beausoleil, M., Fortier, N., Guénette, S., L’Ecuyer, A., Savoie, M., Franco, M., Lachaîne, J., & Weiss, K. (2007) · Canadian Journal of Gastroenterology · doi:10.1155/2007/720205 · Cited by 162
“Exclusion criteria included active diarrhea at enrollment, diagnosis of C difficile-associated diarrhea (CDAD) within the previous three months, antibiotic treatment with vancomycin or an aminoglycoside in monotherapy (23), confirmed lactose intolerance, underlying chronic GI tract disease, patients with stomas, use o…”
BackgroundCindoruk, M., Erkan, G., Karakan, T., Dursun, A., & Unal, S. (2007) · Helicobacter · doi:10.1111/j.1523-5378.2007.00516.x · Cited by 135
Managing antibiotic associated diarrhoea: Probiotics may help in prevention
Barbut, F., & Meynard, J. L. (2002) · BMJ · doi:10.1136/bmj.324.7350.1345 · Cited by 100
Probiotics reduce symptoms of antibiotic use in a hospital setting: A randomized dose response study
Ouwehand, A. C., DongLian, C., Weijian, X., Stewart, M., Ni, J., Stewart, T., & Miller, L. E. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.11.053 · Cited by 98
Neut, C., Mahieux, S., & Dubreuil, L. J. (2017) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2017.07.001 · Cited by 96
Jafarnejad, S., Shab‐Bidar, S., Speakman, J. R., Parastui, K., Daneshi‐Maskooni, M., & Djafarian, K. (2016) · Nutrition in Clinical Practice · doi:10.1177/0884533616639399 · Cited by 68
Merenstein, D. J., Foster, J., & D’Amico, F. (2009) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2009.119 · Cited by 61
Song, H. J., Kim, J.-Y., Jung, S.-A., Kim, S.-E., Park, H.-S., Jeong, Y., Hong, S. P., Cheon, J. H., Kim, W. H., Kim, H.-J., et al. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.12.1784 · Cited by 58
Xie, C., Li, J., Wang, K., Li, Q., & Chen, D. (2015) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2015.03.001 · Cited by 49
McFarland, L. V. (2013) · World Journal of Meta-Analysis · doi:10.13105/wjma.v1.i3.102 · Cited by 33
Self-citation
Metadata
- Authors
- McFarland, L. V.
- Venue
- Digestive Diseases
- Publisher
- S. Karger AG
- Published
- 1998
- Volume
- 16
- Issue
- 5
- Pages
- 292-307
- ISSN
- 0257-2753 (ISSN-L)
- 1421-9875
- OpenAlex
- W2062482987
- Cited by
- 310
- References
- 98
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.